Inactive Instrument

News Herantis Pharma Oyj Nasdaq Helsinki

Equities

FI4000087861

Summary

Unlock all the news: Be the first to know and act before the market!

Herantis Pharma Submits Clinical Trial Application for A Phase 1B Clinical Trial of Her-096	05-20	CI
Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	03-06	CI
Transcript : Herantis Pharma Oyj, 2023 Earnings Call, Mar 06, 2024	03-06
Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle	01-26	AQ
Herantis Pharma Oyj : Minutes of Herantis Pharma Plc’s extraordinary general meeting of shareholders November 17, 2023	11-16	PU
Herantis Pharma Oyj : Notice to Convene Herantis Pharma Plc's Extraordinary General Meeting of Shareholders November 17, 2023	11-15	PU
Transcript : Herantis Pharma Oyj - Special Call	23-10-25
Herantis Pharma's Early-stage Study of Parkinson's Therapy Shows Positive Data; Stock Surges	23-10-25	MT
Herantis Pharma Plc Announces Positive Topline Data from Phase 1a Clinical Trial of HER-096	23-10-25	CI
Herantis Pharma Secures EUR4.5 Million Loan Waive-off From Business Finland	23-09-25	MT
Transcript : Herantis Pharma Oyj, H1 2023 Earnings Call, Aug 24, 2023	23-08-24
Herantis Pharma Oyj Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Herantis Pharma plc Announces First Healthy Volunteers Dosed in the Part 2 of the Her-096 Phase 1A Clinical Study	23-08-22	CI
Herantis Pharma Plc's shares subscribed with option rights	23-07-19	AQ
Herantis Pharma Plc announcing start of recruitment of healthy volunteers for part 2 of the ongoing Phase 1a clinical study of HER-096	23-07-04	AQ
Herantis Pharma Plc Announces Start of Recruitment of Healthy Volunteers for Part 2 of the Ongoing Phase 1a Clinical Study of HER-096	23-07-04	CI
Herantis Pharma Oyj: Managers' Transactions - Aki Prihti	23-06-20	AQ
Herantis Pharma Oyj: Managers' Transactions - Timo Veromaa	23-06-20	AQ
Herantis Pharma Oyj: Managers' Transactions - Frans Wuite	23-06-20	AQ
Herantis Pharma Oyj: Managers' Transactions - Tone Kvåle	23-06-09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Herantis Pharma Oyj Nasdaq Helsinki

Equities

FI4000087861

Summary

Filters